🔗 Permalink

Inventor profile of:

Aesop CHO

City:

Mountain View, California

Country:

United States

Published Applications:

Last publication date:

2025-08-28

Top Assignees for applications by Aesop CHO

The entities that hold a legal rights for patent applications filed by inventor CHO Aesop:

Gilead Sciences, Inc. 53 Foster City, CA United States
GILEAD PHARMASSET LLC 4 Foster City, CA United States
Trine Pharmaceuticals, Inc. 2 Waltham, MA United States
DAIICHI PHARMACEUTICAL CO., LTD. 2 Tokyo, Japan

Recent patent applications by CHO Aesop

Aesop CHO from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-28

US20250270195A1

Chemistry; metallurgy

PD-1/PD-L1 INHIBITORS

#2 | 2025-05-29

US20250171413A1

Chemistry; metallurgy

ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF

#3 | 2024-03-28

US20240101529A1

Chemistry; metallurgy

ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF

#4 | 2023-07-06

US20230212155A1

Chemistry; metallurgy

PD-1/PD-L1 INHIBITORS

#5 | 2021-12-30

US20210403497A1

Chemistry; metallurgy

PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1`-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS

#6 | 2021-10-21

US20210323922A1

Chemistry; metallurgy

PD-1/PD-L1 INHIBITORS

#7 | 2021-03-18

US20210078959A1

Chemistry; metallurgy

HIV protease inhibitors

#8 | 2021-02-25

US20210053946A1

Chemistry; metallurgy

PD-1/PD-L1 inhibitors

#9 | 2021-01-28

US20210024494A1

Chemistry; metallurgy

PD-1/PD-L1 inhibitors

#10 | 2020-11-05

US20200345699A1

Human necessities

HIV protease inhibitors

#11 | 2020-01-16

US20200017471A1

Chemistry; metallurgy

PD-1/PD-L1 inhibitors

#12 | 2019-11-14

US20190345131A1

Chemistry; metallurgy

PD-1/PD-L1 inhibitors

#13 | 2019-09-05

US20190270727A1

Chemistry; metallurgy

PD-1/PD-L1 inhibitors

#14 | 2019-07-11

US20190210978A1

Chemistry; metallurgy

HIV protease inhibitors

#15 | 2018-11-15

US20180327437A1

Chemistry; metallurgy

Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs

#16 | 2018-10-25

US20180305315A1

Chemistry; metallurgy

PD-1/PD-L1 INHIBITORS

#17 | 2017-02-02

US20170029408A1

Chemistry; metallurgy

Antiviral compounds

#18 | 2015-03-19

US20150080569A1

Chemistry; metallurgy

ANTIVIRAL COMPOUNDS

#19 | 2015-01-22

US20150025039A1

Chemistry; metallurgy

Antiviral phosphonate analogs

#20 | 2014-09-04

US20140249074A1

Human necessities

Antiviral compounds

#21 | 2014-02-20

US20140051656A1

Chemistry; metallurgy

Antiviral compounds

#22 | 2014-02-06

US20140039021A1

Chemistry; metallurgy

Antiviral compounds

#23 | 2013-12-26

US20130344028A2

Chemistry; metallurgy

1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

#24 | 2013-11-28

US20130316969A1

Chemistry; metallurgy

Antiviral phosphonate analogs

#25 | 2013-11-14

US20130302280A1

Chemistry; metallurgy

Inhibitors of flaviviridae viruses

#26 | 2013-10-24

US20130281686A1

Chemistry; metallurgy

Methods for the preparation of diasteromerically pure phosphoramidate prodrugs

#27 | 2013-10-17

US20130274439A1

Chemistry; metallurgy

Antiviral compounds

#28 | 2013-05-30

US20130137877A1

Chemistry; metallurgy

Antiviral compounds

#29 | 2013-02-28

US20130053577A1

Chemistry; metallurgy

Antiviral compounds

#30 | 2013-02-07

US20130034521A1

Chemistry; metallurgy

1′-substituted carba-nucleoside analogs for antiviral treatment

#31 | 2012-10-18

US20120263678A1

Chemistry; metallurgy

1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment

#32 | 2012-07-26

US20120190866A1

Chemistry; metallurgy

Antiviral compounds

#33 | 2012-06-21

US20120156166A1

Chemistry; metallurgy

Inhibitors of viruses

#34 | 2012-01-26

US20120020921A1

Chemistry; metallurgy

1′-substituted-carba-nucleoside prodrugs for antiviral treatment

#35 | 2012-01-12

US20120009147A1

Chemistry; metallurgy

2'-fluoro substituted carba-nucleoside analogs for antiviral treatment

#36 | 2011-12-01

US20110293563A1

Chemistry; metallurgy

1′substituted carba-nucleoside analogs for antiviral treatment

#37 | 2011-11-24

US20110288053A1

Chemistry; metallurgy

ANTIVIRAL PHOSPHONATE ANALOGS

#38 | 2011-09-22

US20110230654A1

Chemistry; metallurgy

Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs

#39 | 2011-04-07

US20110082112A1

Chemistry; metallurgy

Antiviral phosphinate compounds

#40 | 2011-04-07

US20110081314A1

Chemistry; metallurgy

Antiviral phosphinate compounds

#41 | 2011-03-24

US20110071101A1

Chemistry; metallurgy

Nucleoside Phosphonate Analogs

#42 | 2011-03-24

US20110070194A1

Chemistry; metallurgy

2'-fluoro substituted carba-nucleoside analogs for antiviral treatment

#43 | 2010-08-12

US20100203015A1

Chemistry; metallurgy

Carba-nucleoside analogs for antiviral treatment

#44 | 2010-01-28

US20100022467A1

Human necessities

ANTI-CANCER PHOSPHONATE ANALOGS

#45 | 2010-01-28

US20100021425A1

Chemistry; metallurgy

1′-substituted carba-nucleoside analogs for antiviral treatment

#46 | 2009-12-24

US20090317361A1

Chemistry; metallurgy

Carba-nucleoside analogs for antiviral treatment

#47 | 2009-11-05

US20090275535A1

Chemistry; metallurgy

Antiviral phosphonate analogs

#48 | 2009-10-15

US20090257978A1

Chemistry; metallurgy

Antiviral compounds

#49 | 2009-10-01

US20090247488A1

Chemistry; metallurgy

ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS

#50 | 2009-09-10

US20090227543A1

Human necessities

PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY

#51 | 2009-09-10

US20090227491A1

Chemistry; metallurgy

ANTIVIRAL PHOSPHINATE COMPOUNDS

#52 | 2009-07-16

US20090181930A1

Human necessities

KINASE INHIBITORY PHOSPHONATE ANALOGS

#53 | 2009-05-21

US20090131372A1

Human necessities

PHOSPHONATE ANALOGS FOR TREATING METABOLIC DISEASES

#54 | 2009-02-19

US20090047252A1

Chemistry; metallurgy

Antiviral compounds

#55 | 2008-07-17

US20080171724A1

Chemistry; metallurgy

Phosphonate Derivatives of Mycophenolic Acid

#56 | 2008-07-10

US20080167270A1

Chemistry; metallurgy

ANTI-INFECTIVE PHOSPHONATE ANALOGS

#57 | 2008-03-06

US20080057031A1

Chemistry; metallurgy

Antiviral phosphinate compounds

#58 | 2007-03-29

US20070072809A1

Chemistry; metallurgy

Antiviral compounds

#59 | 2007-02-01

US20070027116A1

Chemistry; metallurgy

Therapeutic phosphonate derivatives

#60 | 2007-02-01

US20070027113A1

Human necessities

Purine nucleoside phosphorylase inhibitory phosphonate compounds

#61 | 2006-11-23

US20060264404A1

Chemistry; metallurgy

Therapeutic phosphonate compounds

#62 | 2006-09-07

US20060199788A1

Chemistry; metallurgy

Anti-inflammatory phosphonate compounds

#63 | 2006-06-06

US9842234

Drug efflux pump inhibitor

#64 | 2006-05-18

US20060106034A1

Chemistry; metallurgy

Drug efflux pump inhibitor

#65 | 2006-04-13

US20060079478A1

Human necessities

Anti-cancer phosphonate analogs

#66 | 2006-02-16

US20060035866A1

Human necessities

Phosphonate compounds having immuno-modulatory activity

#67 | 2005-11-24

US20050261253A1

Human necessities

Kinase inhibitory phosphonate analogs

#68 | 2005-11-24

US20050261237A1

Chemistry; metallurgy

Nucleoside phosphonate analogs

#69 | 2005-11-17

US20050256078A1

Chemistry; metallurgy

Inosine monophosphate dehydrogenase inhibitory phosphonate compounds

#70 | 2005-10-13

US20050227947A1

Human necessities

Phosphonate analogs for treating metabolic diseases

#71 | 2005-09-29

US20050215525A1

Chemistry; metallurgy

Anti-infective phosphonate analogs

#72 | 2005-09-29

US20050215513A1

Chemistry; metallurgy

Antiviral phosphonate analogs

InventorID:

77943 ⎘